XCancer

ImmunoPET Imaging With 89Zr-DFO-REGN3767 in Patients With Advanced Solid Cancer Prior to and During Treatment With Cemiplimab With or Without Platinum-based Chemotherapy

Description:

This is an investigator-initiated, single-center, open-label clinical trial designed to evaluate the safety and PK of the PET tracer 89Zr-DFO-REGN3767 in patients prior to and during treatment.

Sponsor:

University Medical Center Groningen

Contacts:

E GE de Vries, MD, PhD (Principal Investigator)

e.g.e.de.vries@umcg.nl

+31503612934

P P van de Donk, MD

p.p.van.de.donk01@umcg.nl

+31503616161

Government Study Link:

NCT04706715 - Click here to see study on

ClinicalTrials.gov